US Customs Ruling (CROSS)
 HS Code : | | |
|---|
 HTS Code : | | |
|---|
Ruling Number :
Issuing Country : UNITED STATES
Date Of Issue : 2022-01-07T00:00:00
Azacitidine Injection in dosage form
Azacitidine Injection is an antineoplastic agent
Azacitidine Injection is an antineoplastic agent. It is indicated for treatment of patients with the following French American British (FAB) myelodysplastic syndrome subtypes: refractory anemia (RA) or refractory anemia with ringed sideroblasts (if accompanied by neutropenia or thrombocytopenia or requiring transfusions), refractory anemia with excess blasts (RAEB), refractory anemia with excess blasts in transformation (RAEB-T), and chronic myelomonocytic leukemia (CMMoL).
Description : Azacitidine Injection in dosage form
Please importantly note that only the relevant portion of the related US Ruling (Cross) is displayed above. You may refer to the said customs ruling for the entire ruling explanation.
Source : US Customs Ruling (CROSS)
source link :